Aquatic Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Aquatic Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.95M	Buy	+97,897	New	+$3.15M	0.08%	290
2025 Q1	–	Sell	-40,824	Closed	-$900K	–	1621
2024 Q4	$900K	Sell	40,824 -212,176	-84%	-$3.86M	0.02%	581
2024 Q3	$4.56M	Buy	253,000 +18,600	+8%	+$326K	0.12%	206
2024 Q2	$3.81M	Buy	234,400 +187,400	+399%	+$2.89M	0.14%	147
2024 Q1	$663K	Buy	47,000 +33,700	+253%	+$425K	0.02%	483
2023 Q4	$139K	Buy	+13,300	New	+$124K	﹤0.01%	935
2023 Q3	–	Sell	-87,200	Closed	-$657K	–	1645
2023 Q2	$657K	Sell	87,200 -43,100	-33%	-$349K	0.04%	395
2023 Q1	$1.15M	Buy	+130,300	New	+$1.29M	0.07%	253
2022 Q3	–	Sell	-57,500	Closed	-$432K	–	1543
2022 Q2	$432K	Buy	+57,500	New	+$501K	0.14%	181
2022 Q1	–	Sell	-52,400	Closed	-$420K	–	1514
2021 Q4	$420K	Buy	+52,400	New	+$473K	0.81%	5

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aquatic Capital Management's TEVA Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 97,897 shares worth $2.95M. The stake represents 0.08% of the portfolio and ranks #290 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in TEVA as recently as Q4 2024.

Aquatic Capital Management first reported a position in TEVA in Q4 2021 and has held it in 10 quarters since. The position peaked at $4.56M in Q3 2024. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Aquatic Capital Management held 97,897 shares of Teva Pharmaceuticals worth $2.95M as of Q1 2026.
Teva Pharmaceuticals was a new Aquatic Capital Management position in Q1 2026.
Teva Pharmaceuticals made up 0.08% of Aquatic Capital Management's portfolio in Q1 2026, its #290 holding.
Aquatic Capital Management first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
Aquatic Capital Management's Teva Pharmaceuticals position peaked at $4.56M in Q3 2024.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.